| |
|
|
|
Therapix Biosciences Ltd.  
|
|
0 (0%) |
|
|
Open: |
|
Pre close: |
|
Target:
|
0.15
|
|
High: |
|
Low: |
|
Resistance:
|
0.13
0.17
|
|
Volume: |
|
Market Cap: |
0M |
Support:
|
0.06
0.05
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.09
 |
MACD |
MACD(12,26):
|
-0.02 |
|
MA(20): |
0.12 |
Signal(12,26,9): |
-0.02  |
|
MA(100): |
0.32 |
Stochastic Oscillator |
%K(14,3):
|
26.06 |
|
MA(250): |
0.70 |
%D(3): |
19.69 |
|
Average Volume(K) |
3-Month: |
7167
|
52-Week |
High:
|
3.15 |
|
10-Days: |
4639 |
Low: |
0.06 |
|
RSI |
RSI(14):
|
34.13 |
Change(%): |
-96.1 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
0.00 |
|
EPS Est. Current Year |
-1.520 |
Return on Assets (ttm) |
0.0 |
Shares Float (M) |
0.00 |
|
EPS Est. Next Year |
-2.130 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.550 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
0.00 |
|
Forward EPS |
-0.319 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
0.000 |
EBITDA (p.s.) |
-0.687 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.00 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
